Ágnes Doszpoly (@agnesdoszpoly) 's Twitter Profile
Ágnes Doszpoly

@agnesdoszpoly

Think positive, like a proton 👩🏼‍🔬 PhD Candidate @PurdueBME TKU Lab 🔬 neuroengineering and diabetes researcher🤓 Women in STEM supporter, feminist

ID: 1144345563476963328

calendar_today27-06-2019 20:43:38

47 Tweet

32 Takipçi

184 Takip Edilen

Center for Diabetes and Metabolic Diseases (@iusweettweets) 's Twitter Profile Photo

The Diabetologia #OpenAccess study from Amelia Linnemann, Ph.D. provides evidence of islet macroautophagy/crinophagy impairment in human #T1D and demonstrates altered lysosome content that may be associated with lysosome dysfunction before clinical hyperglycemia.

Purdue Exponent (@purdueexponent) 's Twitter Profile Photo

A number of student organizations marched from Armstrong Hall to Hovde Hall Friday afternoon in protest of Purdue President Mitch Daniels' open letter. purdueexponent.org/gallery/featur…

Center for Diabetes and Metabolic Diseases (@iusweettweets) 's Twitter Profile Photo

We're still buzzing with excitement over the good news! ICYMI: Our IU School of Medicine researchers with Type 1 Diabetes TrialNet helped contribute to the first FDA-approved drug to delay the onset of #Type1Diabetes. medicine.iu.edu/news/2022/11/t…

OmniVis (@omnivistech) 's Twitter Profile Photo

We are excited to announce that OmniVis won the Purdue Research Foundation Ag-Celerator! Co-founder Dr. Tamara Kinzer-Ursem gave a stellar pitch. We are excited for this honor and can't wait for next steps to help the world with #foodsafety. purdue.edu/newsroom/relea…

Center for Diabetes and Metabolic Diseases (@iusweettweets) 's Twitter Profile Photo

3 of our IU researchers are headed to Italy this spring for the next Pancreatic Diseases conference! There is still time to register and join them for a week full of exceptional presentations and discussions on all things pancreas. Learn more: grc.org/pancreatic-dis….

3 of our IU researchers are headed to Italy this spring for the next Pancreatic Diseases conference! There is still time to register and join them for a week full of exceptional presentations and discussions on all things pancreas. Learn more: grc.org/pancreatic-dis….
Hareem Tariq (@hareem_tariq) 's Twitter Profile Photo

Presented my work at SURF SYMPOSIUM held at Purdue University to a larger audience, and it was truly an exhilarating moment! I cannot express enough gratitude for the unwavering support and guidance of my exceptional mentors Ágnes Doszpoly , my PI Dr. Tamara Kinzer-Ursem. #Purduecohort

Presented my work at SURF SYMPOSIUM held at Purdue University to a larger audience, and it was truly an exhilarating moment! 
I cannot express enough gratitude for the unwavering support and guidance of my exceptional mentors <a href="/AgnesDoszpoly/">Ágnes Doszpoly</a> , my PI <a href="/KinzerUrsem/">Dr. Tamara Kinzer-Ursem</a>. 
#Purduecohort
The Nobel Prize (@nobelprize) 's Twitter Profile Photo

BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
Emily K. Sims (@emksims) 's Twitter Profile Photo

Excited to share this huge group effort led by Jamie Felton as part of the #PMDIinitiative: an open access systematic review of T1D disease-modifying therapies and analyses of treatment responses: rdcu.be/dnKA6 . Thread: (1/4) nature.com/articles/s4385…

Center for Diabetes and Metabolic Diseases (@iusweettweets) 's Twitter Profile Photo

Congrats to our IU School of Medicine IU Department of Pediatrics Type 1 Diabetes Connection Riley Children's diabetes research team, honored this morning as #IBJHealthCareHeroes! The group was recognized for their innovative research and clinical work with teplizumab, the first FDA-approved drug to delay the onset of #T1D

Congrats to our <a href="/IUMedSchool/">IU School of Medicine</a> <a href="/IUDeptPeds/">IU Department of Pediatrics</a> <a href="/T1DIndy/">Type 1 Diabetes Connection</a> <a href="/RileyChildrens/">Riley Children's</a> diabetes research team, honored this morning as #IBJHealthCareHeroes! The group was recognized for their innovative research and clinical work with teplizumab, the first FDA-approved drug to delay the onset of #T1D